Cargando…

Phenotypic Heterogeneity of Triple-Negative Breast Cancer Mediated by Epithelial–Mesenchymal Plasticity

SIMPLE SUMMARY: Epithelial–mesenchymal transition (EMT) and its reverse process mesenchymal–epithelial transition (MET) are considered critical events in the cancer progression. These programs are tightly connected with the development of metastasis–the lethal stage of the disease. Both EMT and MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kvokačková, Barbora, Remšík, Ján, Jolly, Mohit Kumar, Souček, Karel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125677/ https://www.ncbi.nlm.nih.gov/pubmed/34063254 http://dx.doi.org/10.3390/cancers13092188

Ejemplares similares

Single‐cell protein profiling defines cell populations associated with triple‐negative breast cancer aggressiveness
por: Kvokačková, Barbora, et al.
Publicado: (2023)

Editorial: Heterogeneity and plasticity of prostate cancer
por: Culig, Zoran, et al.
Publicado: (2023)

Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer
por: Remšík, Ján, et al.
Publicado: (2018)

TGF-β regulates Sca-1 expression and plasticity of pre-neoplastic mammary epithelial stem cells
por: Remšík, Ján, et al.
Publicado: (2020)

Prognostic value and multifaceted roles of tetraspanin CD9 in cancer
por: Ondruššek, Róbert, et al.
Publicado: (2023)

Phenotypic heterogeneity drives differential disease outcome in a mouse model of triple negative breast cancer
por: Thankamony, Archana P., et al.
Publicado: (2023)

Quantifying the Patterns of Metabolic Plasticity and Heterogeneity along the Epithelial–Hybrid–Mesenchymal Spectrum in Cancer
por: Muralidharan, Srinath, et al.
Publicado: (2022)

Mapping phenotypic heterogeneity in melanoma onto the epithelial-hybrid-mesenchymal axis
por: Pillai, Maalavika, et al.
Publicado: (2022)

ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance
por: Drápela, Stanislav, et al.
Publicado: (2020)

Population Dynamics of Epithelial-Mesenchymal Heterogeneity in Cancer Cells
por: Jain, Paras, et al.
Publicado: (2022)

Systems-level network modeling deciphers the master regulators of phenotypic plasticity and heterogeneity in melanoma
por: Pillai, Maalavika, et al.
Publicado: (2021)

An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancers
por: Rajarajan, Savitha, et al.
Publicado: (2023)

A mechanism for epithelial-mesenchymal heterogeneity in a population of cancer cells
por: Tripathi, Shubham, et al.
Publicado: (2020)

Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer
por: Bhatt, Akshita B., et al.
Publicado: (2019)

Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity
por: Strauss, Robert, et al.
Publicado: (2011)

High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells
por: Šimečková, Šárka, et al.
Publicado: (2019)

Link between glucose metabolism and epithelial-to-mesenchymal transition drives triple-negative breast cancer migratory heterogeneity
por: Schwager, Samantha C., et al.
Publicado: (2022)

Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells
por: Slabáková, Eva, et al.
Publicado: (2015)

Insights into the Multi-Dimensional Dynamic Landscape of Epithelial–Mesenchymal Plasticity through Inter-Disciplinary Approaches
por: Kumar Jolly, Mohit, et al.
Publicado: (2020)

Gene expression profiles of inflammatory breast cancer reveal high heterogeneity across the epithelial-hybrid-mesenchymal spectrum
por: Chakraborty, Priyanka, et al.
Publicado: (2021)

Alternative mechanisms of miR-34a regulation in cancer
por: Slabáková, Eva, et al.
Publicado: (2017)

Correction Alternative mechanisms of miR-34a regulation in cancer
por: Slabáková, Eva, et al.
Publicado: (2018)

Landscape of epithelial–mesenchymal plasticity as an emergent property of coordinated teams in regulatory networks
por: Hari, Kishore, et al.
Publicado: (2022)

Analysis of immune subtypes across the epithelial-mesenchymal plasticity spectrum
por: Chakraborty, Priyanka, et al.
Publicado: (2021)

Correction: Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity
por: Strauss, Robert, et al.
Publicado: (2011)

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
por: Al-Khadairi, Ghaneya, et al.
Publicado: (2019)

Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype
por: Sahoo, Sarthak, et al.
Publicado: (2021)

Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
por: Jolly, Mohit Kumar, et al.
Publicado: (2015)

Dynamics of Epithelial–Mesenchymal Plasticity: What Have Single-Cell Investigations Elucidated So Far?
por: Subhadarshini, Seemadri, et al.
Publicado: (2023)

CD155 contributes to the mesenchymal phenotype of triple‐negative breast cancer
por: Zheng, Qianqian, et al.
Publicado: (2020)

Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity
por: Jolly, Mohit Kumar, et al.
Publicado: (2018)

NRF2-dependent Epigenetic Regulation can Promote the Hybrid Epithelial/Mesenchymal Phenotype
por: Jia, Wen, et al.
Publicado: (2022)

Interrogation of Phenotypic Plasticity between Epithelial and Mesenchymal States in Breast Cancer
por: Bhatia, Sugandha, et al.
Publicado: (2019)

Stability of the hybrid epithelial/mesenchymal phenotype
por: Jolly, Mohit Kumar, et al.
Publicado: (2016)

Multi-modal transcriptomic analysis unravels enrichment of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer
por: Sahoo, Sarthak, et al.
Publicado: (2023)

Implications of Epithelial–Mesenchymal Plasticity for Heterogeneity in Colorectal Cancer
por: Pereira, Lloyd, et al.
Publicado: (2015)

The Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy and the Epithelial–Mesenchymal Transition
por: Zapperi, Stefano, et al.
Publicado: (2023)

Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer
por: Brown, Meredith S., et al.
Publicado: (2022)

Heterogeneous Manifestations of Epithelial–Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients
por: Tashireva, Liubov A., et al.
Publicado: (2021)

Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response
por: Jia, Dongya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v375g5n8h64diolson9dh5o999